Jackson
Hammond, Health Care Policy Analyst
This
week the U.S. Food and Drug Administration (FDA) issued its first authorization of an electronic nicotine delivery system (ENDS)
product, more commonly known as e-cigarettes. While manufacturers argue ENDS
products help adults with smoking cessation, there are concerns about the use
of these products by young adults and teenagers. The chart below compares two
studies: The first study looked at the likelihood of ENDS products
enabling smoking cessation in adults; the second study examined the likelihood of ENDS products
leading to traditional cigarette use in teenagers. The first study, a
meta-analysis, found that adults who used e-cigarettes daily were 1.5 times
more likely to quit traditional cigarettes than those who did not use
e-cigarettes. The second study, also a meta-analysis, found that teenagers who
began nicotine use with e-cigarettes were 2.75 times more likely to transition
to traditional cigarettes than those who did not use e-cigarettes. While many
questions remain regarding the impact of e-cigarettes on both traditional
cigarette uptake and cessation, it is clear more information is needed—and that
this remains a hazy policy area with tough choices.
Disclaimer Christopher Holt is the Director of Health Care Policy at the American
Action Forum.
https://www.americanactionforum.org/weekly-checkup/risk-pool-dangers-of-year-round-open-enrollment/#ixzz79iIFq9aI
Follow @AAF on Twitter
No comments:
Post a Comment